Publication:
Pivotal role of plasminogen-activator inhibitor 1 in vascular disease

dc.contributor.authorsAgirbasli, M
dc.date.accessioned2022-03-10T15:24:59Z
dc.date.accessioned2026-01-11T13:14:23Z
dc.date.available2022-03-10T15:24:59Z
dc.date.issued2005
dc.description.abstractFibrinolysis plays a crucial role in the development of vascular disease. The interface between the plasminogen activators and inhibitors determines the fibrinolytic potential of human blood. In addition to fibrin degradation, fibrinolytic system components modulate several complex biological events such as angiogenesis, tumorigenesis, arteriosclerosis and cellular migration. Recent experimental and clinical data indicated that PAI-1 as a novel vascular risk factor. In this concise review, we will examine the accumulating evidence suggesting that there is an intricate relationship between these systems which may provide new therapeutic strategies for prevention of vascular disease. (C) 2005 Blackwell Publishing Ltd.
dc.identifier.doi10.1111/j.1742-1241.2005.00379.x
dc.identifier.eissn1742-1241
dc.identifier.issn1368-5031
dc.identifier.pubmed15707473
dc.identifier.urihttps://hdl.handle.net/11424/220047
dc.identifier.wosWOS:000226938200019
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofINTERNATIONAL JOURNAL OF CLINICAL PRACTICE
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectplasminogen-activator inhibitor 1
dc.subjectatherosclerosis
dc.subjectthrombosis
dc.subjectRENIN-ANGIOTENSIN SYSTEM
dc.subjectFAST-ACTING INHIBITOR
dc.subjectENDOTHELIAL-CELLS
dc.subjectRAPID INHIBITOR
dc.subjectHEPATOMA-CELLS
dc.subjectHUMAN-PLASMA
dc.subjectIN-VITRO
dc.subjectPAI-1
dc.subjectGENE
dc.subjectPURIFICATION
dc.titlePivotal role of plasminogen-activator inhibitor 1 in vascular disease
dc.typereview
dspace.entity.typePublication
oaire.citation.endPage106
oaire.citation.issue1
oaire.citation.startPage102
oaire.citation.titleINTERNATIONAL JOURNAL OF CLINICAL PRACTICE
oaire.citation.volume59

Files